4771 - 4780 of 8399 Results
Title
Year
-
OPENTitle: Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 1Start Page: 35End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2020.05.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671949Citation Count: 5
-
OPENTitle: Inconsistent Movement Disorders Society–Unified Parkinson's Disease Rating Scale Part III Ratings in the Parkinson's Progression Marker InitiativeJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1488End Page: 1489Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28108Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022849Citation Count: 11
- Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain2020OPENTitle: Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 23Issue #: 6Start Page: 696End Page: 700Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-020-0635-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269838Citation Count: 118
-
OPENTitle: The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotensionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 75Issue #:Start Page: 97End Page: 104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415666Citation Count: 46
-
OPENTitle: Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohortJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-020-01777-2Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-020-01777-2Citation Count: 18
-
OPENTitle: Managing Device‐Aided Treatments in Parkinson's Disease in Times of COVID‐19Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 737End Page: 738Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12985Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12985Citation Count: 2
- Beta Agonists and Progression of Parkinson's Disease in Older Adults: A Retrospective Cohort Study2020RESTRICTEDTitle: Beta Agonists and Progression of Parkinson's Disease in Older Adults: A Retrospective Cohort StudyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 7Start Page: 1275End Page: 1277Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28085Citation Count: 4
-
OPENTitle: Genetic characterization of Parkinson's disease patients in Ecuador and ColombiaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 75Issue #:Start Page: 27End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236935Citation Count: 8
-
OPENTitle: Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington diseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 6Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000430Best OA location URL: https://ng.neurology.org/content/nng/6/3/e430.full.pdfCitation Count: 8
-
OPENTitle: LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived NeuronsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00442Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00442/pdfCitation Count: 39